Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Health Care Reform Plan To Favor Government-Made Drugs

This article was originally published in PharmAsia News

Executive Summary

China's new three-year health care reform guidelines include a system designed to force down the cost of prescription drugs deemed essential. The government itself is to produce and distribute essential medicines under its own control and supervision. It plans to issue a list of such drugs later this year. The number of drugs to be placed on the list has not been disclosed, but the Ministry of Health had said earlier it would be based on the 400 drugs the World Health Organization recommends be accessible. Those considered essential are based on the prevalence of a disease and the comparative cost-effectiveness of the drugs. (Click here for more)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071544

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel